CDK2 and neoplasm: Alterations to cyclin D1, CDK1, CDK2, CDK4 and p16, which regulate the cell cycle, led us to speculate whether ABHD11‐AS1 affects tumour progression by regulating the protein expression of factors linked to the cell cycle.